Related references
Note: Only part of the references are listed.Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
Roel J. T. Mocking et al.
TRANSLATIONAL PSYCHIATRY (2021)
A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling
Anderson Camargo et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
Priscila B. Rosa et al.
PURINERGIC SIGNALLING (2021)
A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice
Daiane B. Fraga et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
Vesna Lazarevic et al.
MOLECULAR PSYCHIATRY (2021)
Guanosine fast onset antidepressant-like effects in the olfactory bulbectomy mice model
Roberto Farina de Almeida et al.
SCIENTIFIC REPORTS (2020)
Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway
Anderson Camargo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling
Anderson Camargo et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
Anderson Camargo et al.
EXPERIMENTAL NEUROLOGY (2020)
Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway
Anderson Camargo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine
Naiani Ferreira Marques et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways
Priscila B. Rosa et al.
PURINERGIC SIGNALLING (2019)
Involvement of PI3K/Akt/GSK-3β signaling pathway in the antidepressant-like and neuroprotective effects of Morus nigra and its major phenolic, syringic acid
Ana Paula Dalmagro et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems
Roberto Farina Almeida et al.
MOLECULAR NEUROBIOLOGY (2017)
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Wei Liu et al.
NEURAL PLASTICITY (2017)
The antidepressant-like effect of chronic guanosine treatment is associated with increased hippocampal neuronal differentiation
Luis E. B. Bettio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Novel approaches for the management of depressive disorders
Manuella P. Kaster et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Purine metabolism is dysregulated in patients with major depressive disorder
Toni Ali-Sisto et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Guanosine and its role in neuropathologies
Luis E. B. Bettio et al.
PURINERGIC SIGNALLING (2016)
Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders
Debora Lanznaster et al.
AGING AND DISEASE (2016)
The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation
Valentina Di Liberto et al.
FRONTIERS IN PHARMACOLOGY (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2015)
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress
Manuella P. Kaster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation
Mauricio P. Cunha et al.
PURINERGIC SIGNALLING (2015)
Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress
Luis E. B. Bettio et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions
Tharine Dal-Cim et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling
D. J. Hines et al.
TRANSLATIONAL PSYCHIATRY (2013)
Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways
Luis E. B. Bettio et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Spinal mechanisms of antinociceptive action caused by guanosine in mice
Andre P. Schmidt et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Adenosine and brain function
BB Fredholm et al.
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63 (2005)
Specific [3H]-guanosine binding sites in rat brain membranes
U Traversa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Effect of orally administered guanosine on seizures and death induced by glutamatergic agents
DR Lara et al.
BRAIN RESEARCH (2001)
Share Paper
